Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Shares Outstanding (Diluted Average) (2023 - 2024)

Sagimet Biosciences has reported Shares Outstanding (Diluted Average) over the past 2 years, most recently at $32.1 million for Q3 2024.

  • Quarterly results put Shares Outstanding (Diluted Average) at $32.1 million for Q3 2024, up 424.23% from a year ago — trailing twelve months through Sep 2024 was $32.1 million (up 424.23% YoY), and the annual figure for FY2023 was $10.5 million, changed.
  • Shares Outstanding (Diluted Average) for Q3 2024 was $32.1 million at Sagimet Biosciences, up from $30.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for SGMT hit a ceiling of $32.1 million in Q3 2024 and a floor of $185137.0 in Q1 2023.